Ambroxol PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Ambroxol PCD pharma franchise across India. Our portfolio spans 34 Ambroxol formulations in Drop, Rota Cap, Syrup and Tablet forms, giving franchise partners a strong, ready-to-market basket backed by consistent quality and monopoly-based distribution rights.

What is Ambroxol?

Ambroxol is a mucolytic (mucus-thinning) agent that breaks down thick bronchial secretions, stimulates the production of pulmonary surfactant and improves ciliary clearance, making a productive cough easier to expel. It is widely used in respiratory conditions associated with excessive or viscous mucus. Its properties can be reviewed on PubChem.

Therapeutic Applications

Ambroxol formulations are prescribed for acute and chronic bronchitis, productive cough, COPD, bronchiectasis and other airway disorders with mucus retention, and are frequently combined with expectorants, bronchodilators or antibiotics. Common prescribers include general physicians, pulmonologists, paediatricians and ENT specialists.

Why Ambroxol is a High-Potential Molecule for Distributors

Respiratory and cough preparations form one of the largest and most repeat-driven segments in Indian pharma, with pronounced demand peaks during winter and pollution seasons. Ambroxol's breadth of dosage forms — drops for infants, syrups for children, and tablets and rota-caps for adults — lets a single distributor serve every age group and pair the molecule with fast-moving cough and antibiotic ranges. With 34 formulations on offer, it anchors a complete respiratory division.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Ambroxol
2. MedlinePlus — Cough
3. PubMed — Ambroxol mucolytic literature